APA

Chowdary P., Lethagen S., Friedrich U., Brand B., Hay C., Abdul Karim F., Klamroth R., Knoebl P., Laffan M., Mahlangu J., Miesbach W., Dalsgaard Nielsen J., Martín-Salces M. & Angchaisuksiri P. (20160211). Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. : Journal of thrombosis and haemostasis : JTH.

Chicago

Chowdary P, Lethagen S, Friedrich U, Brand B, Hay C, Abdul Karim F, Klamroth R, Knoebl P, Laffan M, Mahlangu J, Miesbach W, Dalsgaard Nielsen J, Martín-Salces M and Angchaisuksiri P. 20160211. Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. : Journal of thrombosis and haemostasis : JTH.

Harvard

Chowdary P., Lethagen S., Friedrich U., Brand B., Hay C., Abdul Karim F., Klamroth R., Knoebl P., Laffan M., Mahlangu J., Miesbach W., Dalsgaard Nielsen J., Martín-Salces M. and Angchaisuksiri P. (20160211). Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. : Journal of thrombosis and haemostasis : JTH.

MLA

Chowdary P, Lethagen S, Friedrich U, Brand B, Hay C, Abdul Karim F, Klamroth R, Knoebl P, Laffan M, Mahlangu J, Miesbach W, Dalsgaard Nielsen J, Martín-Salces M and Angchaisuksiri P. Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. : Journal of thrombosis and haemostasis : JTH. 20160211.